Fig. 2From: Allergen exposure chambers: implementation in clinical trials in allergen immunotherapyChange in intracutaneous test (ICT) late phase reaction (a) and of baseline- adjusted area under the curve (AUC) of Total Nasal Symptom Score (TNSS) (b); reproduced from [48] with kind permission from WileyBack to article page